10 20 30 40 50 60 70 80 1A0Z - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXYGEN TRANSPORT 08-DEC-97 1A0Z
TITLE HEMOGLOBIN (VAL BETA1 MET) MUTANT
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN (ALPHA CHAIN); COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEMOGLOBIN (BETA CHAIN); COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 CELL: RED BLOOD CELL; SOURCE 7 GENE: HUMAN BETA GLOBIN; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_GENE: HUMAN BETA GLOBIN; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 ORGAN: BLOOD; SOURCE 17 CELL: RED BLOOD CELL; SOURCE 18 GENE: HUMAN BETA GLOBIN; SOURCE 19 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_GENE: HUMAN BETA GLOBIN
KEYWDS OXYGEN TRANSPORT
EXPDTA X-RAY DIFFRACTION
AUTHOR J.S.KAVANAUGH,A.ARNONE
REVDAT 2 24-FEB-09 1A0Z 1 VERSN REVDAT 1 18-MAR-98 1A0Z 0
JRNL AUTH J.S.KAVANAUGH,J.A.WEYDERT,P.H.ROGERS,A.ARNONE JRNL TITL HIGH-RESOLUTION CRYSTAL STRUCTURES OF HUMAN JRNL TITL 2 HEMOGLOBIN WITH MUTATIONS AT TRYPTOPHAN 37BETA: JRNL TITL 3 STRUCTURAL BASIS FOR A HIGH-AFFINITY T-STATE,. JRNL REF BIOCHEMISTRY V. 37 4358 1998 JRNL REFN ISSN 0006-2960 JRNL PMID 9521756 JRNL DOI 10.1021/BI9708702
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.S.KAVANAUGH,P.H.ROGERS,D.A.CASE,A.ARNONE REMARK 1 TITL HIGH-RESOLUTION X-RAY STUDY OF DEOXYHEMOGLOBIN REMARK 1 TITL 2 ROTHSCHILD 37 BETA TRP-->ARG: A MUTATION THAT REMARK 1 TITL 3 CREATES AN INTERSUBUNIT CHLORIDE-BINDING SITE REMARK 1 REF BIOCHEMISTRY V. 31 4111 1992 REMARK 1 REFN ISSN 0006-2960
REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 39110 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1680 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 39549 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4386 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.011 ; 0.010 REMARK 3 ANGLE DISTANCE (A) : 0.026 ; 0.015 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.045 ; 0.030 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.011 ; 0.010 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.133 ; 0.080 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.166 ; 0.200 REMARK 3 MULTIPLE TORSION (A) : 0.162 ; 0.200 REMARK 3 H-BOND (X...Y) (A) : 0.165 ; 0.200 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.800 ; 5.000 REMARK 3 STAGGERED (DEGREES) : 20.100; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 32.300; 25.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.300 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.200 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 8.200 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 11.500; 6.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STARTING MODEL FOR REFINEMENT REMARK 3 WAS AN UNPUBLISHED DEOXYHEMOGLOBIN A STRUCTURE IN THE SAME REMARK 3 CELL.
REMARK 4 REMARK 4 1A0Z COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-95 REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SDMS REMARK 200 DATA SCALING SOFTWARE : SDMS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40065 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : 0.08800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.19900 REMARK 200 R SYM FOR SHELL (I) : 0.19900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.770 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS WITH REMARK 200 DEOXYHEMOGLOBIN A REMARK 200 SOFTWARE USED: PROLSQ REMARK 200 STARTING MODEL: DEOXYHEMOGLOBIN A IN THE SAME CELL, UNPUBLISHED REMARK 200 RESULTS N.-L. CHAN AND A. ARNONE REMARK 200 REMARK 200 REMARK: DEOXYHEMOGLOBIN A IN THE SAME CELL WAS USED AS THE REMARK 200 STARTING MODEL FOR LEAST-SQUARES REFINEMENT
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10.5% PEG 6000 10 MM POTASSIUM REMARK 280 PHOSPHATE PH 7.0 100 MM POTASSIUM CHLORIDE 3 MM SODIUM REMARK 280 DITHIONITE
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.95000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.95000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -106.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 31 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 HIS B 2 N - CA - CB ANGL. DEV. = 14.7 DEGREES REMARK 500 ARG B 40 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG C 31 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP C 64 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP C 85 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP C 85 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG C 92 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG C 92 NE - CZ - NH2 ANGL. DEV. = -6.6 DEGREES REMARK 500 LYS C 99 CB - CA - C ANGL. DEV. = 13.8 DEGREES REMARK 500 LEU C 105 CA - CB - CG ANGL. DEV. = 16.4 DEGREES REMARK 500 ARG D 40 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 LYS D 66 CA - CB - CG ANGL. DEV. = 14.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 75 58.05 -150.30 REMARK 500 LYS A 90 -69.75 -107.14 REMARK 500 LEU C 113 71.90 -116.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 104 0.17 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 179 DISTANCE = 5.16 ANGSTROMS REMARK 525 HOH D 235 DISTANCE = 5.09 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 142 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 147 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM C 142 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM D 147
DBREF 1A0Z A 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1A0Z B 2 146 UNP P68871 HBB_HUMAN 2 146 DBREF 1A0Z C 1 141 UNP P69905 HBA_HUMAN 1 141 DBREF 1A0Z D 2 146 UNP P68871 HBB_HUMAN 2 146
SEQRES 1 A 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 MET HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 C 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 C 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 C 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 146 MET HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS
HET HEM A 142 43 HET HEM B 147 43 HET HEM C 142 43 HET HEM D 147 43
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETSYN HEM HEME
FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 9 HOH *218(H2 O)
HELIX 1 1 PRO A 4 GLY A 18 1 15 HELIX 2 2 HIS A 20 SER A 35 1 16 HELIX 3 3 PRO A 37 TYR A 42 5 6 HELIX 4 4 ALA A 53 ALA A 71 1 19 HELIX 5 5 VAL A 73 ALA A 79 5 7 HELIX 6 6 SER A 81 HIS A 89 1 9 HELIX 7 7 PRO A 95 HIS A 112 5 18 HELIX 8 8 PRO A 119 LEU A 136 1 18 HELIX 9 9 PRO B 5 LYS B 17 1 13 HELIX 10 10 VAL B 20 VAL B 34 1 15 HELIX 11 11 PRO B 36 PHE B 41 5 6 HELIX 12 12 GLU B 43 PHE B 45 5 3 HELIX 13 13 PRO B 51 MET B 55 1 5 HELIX 14 14 PRO B 58 HIS B 77 1 20 HELIX 15 15 LEU B 81 ASP B 94 1 14 HELIX 16 16 PRO B 100 GLU B 121 5 22 HELIX 17 17 PRO B 124 ALA B 142 1 19 HELIX 18 18 PRO C 4 GLY C 18 1 15 HELIX 19 19 HIS C 20 SER C 35 1 16 HELIX 20 20 PRO C 37 TYR C 42 5 6 HELIX 21 21 ALA C 53 ALA C 71 1 19 HELIX 22 22 VAL C 73 ALA C 79 5 7 HELIX 23 23 SER C 81 HIS C 89 1 9 HELIX 24 24 PRO C 95 HIS C 112 5 18 HELIX 25 25 PRO C 119 LEU C 136 1 18 HELIX 26 26 PRO D 5 LYS D 17 1 13 HELIX 27 27 VAL D 20 VAL D 34 1 15 HELIX 28 28 PRO D 36 PHE D 41 5 6 HELIX 29 29 GLU D 43 PHE D 45 5 3 HELIX 30 30 PRO D 51 MET D 55 1 5 HELIX 31 31 PRO D 58 HIS D 77 1 20 HELIX 32 32 LEU D 81 THR D 84 1 4 HELIX 33 33 ALA D 86 ASP D 94 1 9 HELIX 34 34 PRO D 100 GLU D 121 5 22 HELIX 35 35 PRO D 124 ALA D 142 1 19
LINK FE HEM A 142 NE2 HIS A 87 1555 1555 2.25 LINK FE HEM B 147 NE2 HIS B 92 1555 1555 2.22 LINK FE HEM C 142 NE2 HIS C 87 1555 1555 2.22 LINK FE HEM D 147 NE2 HIS D 92 1555 1555 2.24
SITE 1 AC1 12 TYR A 42 PHE A 43 HIS A 45 HIS A 58 SITE 2 AC1 12 LYS A 61 HIS A 87 LEU A 91 VAL A 93 SITE 3 AC1 12 ASN A 97 PHE A 98 LEU A 136 HOH A 173 SITE 1 AC2 11 PHE B 42 HIS B 63 LYS B 66 VAL B 67 SITE 2 AC2 11 LEU B 91 HIS B 92 LEU B 96 ASN B 102 SITE 3 AC2 11 PHE B 103 LEU B 141 HOH B 403 SITE 1 AC3 16 TYR C 42 PHE C 43 HIS C 45 PHE C 46 SITE 2 AC3 16 HIS C 58 LYS C 61 LEU C 86 HIS C 87 SITE 3 AC3 16 LEU C 91 VAL C 93 ASN C 97 PHE C 98 SITE 4 AC3 16 LEU C 101 LEU C 136 HOH C 208 HOH C 285 SITE 1 AC4 9 PHE D 41 HIS D 63 VAL D 67 LEU D 91 SITE 2 AC4 9 HIS D 92 LEU D 96 ASN D 102 PHE D 103 SITE 3 AC4 9 LEU D 141
CRYST1 83.900 112.000 63.700 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011919 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008929 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015699 0.00000
MTRIX1 1 0.949170 -0.050840 0.310630 5.71091 1
MTRIX2 1 -0.050920 -0.998670 -0.007860 90.73637 1
MTRIX3 1 0.310620 -0.008360 -0.950500 -20.81411 1